Free · No Obligation
Free · No Obligation
Ten factors. One score. A plain-English readout of whether answer engines can find, understand, and verify your professional authority.
Get Your Complimentary Score41/100
Illustrative example onlyYour credentials, research, and clinical perspective now determine whether you become part of the answer a patient reads. Before buying more visibility, measure whether AI can see you at all.
There is no charge and nothing to buy. The assessment is complimentary and carries no obligation.
This is a professional visibility assessment. It evaluates public professional information only.
Do not include patient information. Never submit symptoms, medications, diagnoses, or any patient or personal health history.
Questions? corporate@aimwellbio.com
Your assessment request has been submitted. We review each one personally and will send your readout by email.
If you do not hear back, write to corporate@aimwellbio.com.
No pricing applies to this assessment. There are no tiers, no trial, nothing to buy, and no card. If you want to compare what a paid engagement covers, the offerings page lists it; institutional arrangements are handled separately.
A score out of 100 with its letter grade, each of the ten factors scored individually, your weakest area named, your three strongest signals and your three largest gaps — each written as a sentence rather than a code. It arrives by email, usually within a few minutes.
Individual physicians, group practices, health systems and healthcare companies. The scoring model classifies which of those you are before it scores anything, because the questions worth asking about a surgeon are not the questions worth asking about a platform. A practice is never marked down for lacking a developer API.
You can request a review by a member of the team rather than take the automated readout at face value. Reply to the result email, or contact us directly and talk to us about what the score missed.
We fetch the URL you give us exactly as any search engine or answer engine would, and we read what is publicly served. Nothing is logged in, nothing is crawled beyond the address you provide, and no patient information is requested at any point.
Your result is sent to you. It is not published, not added to a directory, and not sold. What we retain and why is set out in the privacy policy. Availability is United States-wide; the service is hosted and requires nothing installed.
Every result carries the scoring model and the rubric version that produced it, and the date it was run. That is deliberate: a score circulated without its version is a number nobody can check. The published standard sets out what each factor measures, and the methodology explains how the corpus behind it is built. Read the standard before you accept the number.
Yes. The assessment is complimentary and carries no obligation. There is no charge, no card, and no pricing attached to it.
We read the single public URL you submit, the way an answer engine would, and send the result to you. It is not published anywhere.
The readout is generated automatically and usually reaches your inbox within a few minutes of submitting the form.
Yes. You can request a review by a member of the team, or contact us directly, and we will go through what the automated readout missed.
A published standard with ten named factors. The scoring model and rubric version appear on every result, so any score can be traced back to the exact rules that produced it.
About this assessment. The AEO/GEO score is an assessment of publicly available professional information and how answer engines can discover, interpret, and verify it. It is not a clinical, diagnostic, or financial evaluation, it does not provide medical advice, and it is offered free of charge with no obligation. The 41/100 shown on this page is an illustrative example, not a real result.
Verification on the AimwellBio platform is credential-based and cannot be purchased. No payment of any kind influences clinical standing, recommendations, prescribing, or patient routing.
Aimwell Partners Inc. (OTCID: AIMN)